Briakinumab and ustekinumab: Anti-p40 antibodies for inflammatory bowel disease treatment

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationCrohn's Disease and Ulcerative Colitis
Subtitle of host publicationFrom Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach: Second Edition
PublisherSpringer International Publishing
Pages367-373
Number of pages7
ISBN (Electronic)9783319337036
ISBN (Print)9783319337012
DOIs
StatePublished - Mar 1 2017

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mannon, P. (2017). Briakinumab and ustekinumab: Anti-p40 antibodies for inflammatory bowel disease treatment. In Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach: Second Edition (pp. 367-373). Springer International Publishing. https://doi.org/10.1007/978-3-319-33703-6_35